Advertisement

Topics

Progenics Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

10:24 EDT 14 Aug 2018 | BioPortfolio Reports

Progenics Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Progenics Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Progenics Pharmaceuticals Progenics or 'the company' is a biopharmaceutical company focused on the development of medicines and products including therapeutic agents and imaging agents for targeting and treating cancer. The company operates in the US, where it is headquartered in New York.


Scope


Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis

An indepth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Original Article: Progenics Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Progenics Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...